Detalhe da pesquisa
1.
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.
Am J Transplant
; 18(7): 1783-1789, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509295
2.
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.
Am J Transplant
; 18(7): 1774-1782, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29573335
3.
The Road to HLA Antibody Evaluation: Do Not Rely on MFI.
Am J Transplant
; 17(6): 1455-1461, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199773
4.
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?
Am J Transplant
; 15(4): 923-30, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778447
5.
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Am J Transplant
; 15(6): 1615-22, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25809272
6.
HLA antibody detection with solid phase assays: great expectations or expectations too great?
Am J Transplant
; 14(9): 1964-75, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25088978
7.
The role of donor-specific HLA alloantibodies in liver transplantation.
Am J Transplant
; 14(4): 779-87, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24580828
8.
Solid-phase assays for the detection of alloantibody against human leukocyte antigens: panacea or Pandora?
Int J Immunogenet
; 41(5): 362-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066258
9.
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
Am J Transplant
; 13(4): 954-960, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23433356
10.
Antibody-mediated rejection--an ounce of prevention is worth a pound of cure.
Am J Transplant
; 11(6): 1131-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21645250
11.
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.
Am J Transplant
; 11(4): 841-7, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21446981
12.
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.
Am J Transplant
; 11(10): 2132-43, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21812918
13.
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.
J Exp Med
; 156(2): 652-7, 1982 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-6980260
14.
Making sense of desensitization.
Am J Transplant
; 10(3): 443-4, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20132170
15.
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients.
Am J Transplant
; 15(1): 284-5, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403877
16.
High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.
Am J Transplant
; 15(10): 2780-1, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26177785
17.
The new kidney allocation system (KAS) and the highly sensitized patient: expect the unexpected.
Am J Transplant
; 14(12): 2917, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274464
18.
In search of perfection.
Am J Transplant
; 13(8): 1951-2, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23837443
19.
Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.
J Clin Invest
; 67(1): 308-11, 1981 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-6969732
20.
HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.
Hum Immunol
; 78(1): 19-23, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27840088